Literature DB >> 8263172

Use of the polymerase chain reaction with a murine model of picornavirus-induced myocarditis.

I Leparc1, F Fuchs, H Kopecka, M Aymard.   

Abstract

Enteroviruses are common pathogens responsible for a wide spectrum of systemic infections. Conventional diagnosis of these infections relies on the isolation of viruses in cell culture and their identification by seroneutralization with polyclonal or monoclonal antibodies. Among enteroviruses, coxsackieviruses B have been involved as causative agents for viral myocarditis. Most of the time, in the case of cardiac pathologies, viral isolation is negative. Molecular biology techniques appear to be an alternative to conventional diagnosis and could supply evidence for the direct implication of enteroviruses in these severe pathologies. In this paper, we describe a murine experimental model of infection with the presumed highly cardiopathogenic coxsackie-virus B type 3. A kinetics of infection was observed for a period of 31 days, and the classical virological markers (viral isolation from feces and heart biopsies, seroconversion) were monitored and compared by means of molecular techniques (molecular hybridization, polymerase chain reaction [PCR]). In this 31-day period, the detection of coxsackievirus B type 3 RNA in the heart was possible only by using two successive seminested PCRs. After 9 to 11 days of active viral replication, when all other virological markers were negative, positive PCR signals were obtained, which supports the hypothesis of a shift to persistent enteroviral infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263172      PMCID: PMC266150          DOI: 10.1128/jcm.31.11.2890-2894.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections.

Authors:  G J Zoll; W J Melchers; H Kopecka; G Jambroes; H J van der Poel; J M Galama
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

Review 2.  Coxsackievirus myocarditis--with special reference to acute and chronic effects.

Authors:  M P Reyes; A M Lerner
Journal:  Prog Cardiovasc Dis       Date:  1985 May-Jun       Impact factor: 8.194

3.  Genome of coxsackievirus B3.

Authors:  A M Lindberg; P O Stålhandske; U Pettersson
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

4.  Selection of coxsackievirus B4 variants with monoclonal antibodies results in attenuation.

Authors:  B S Prabhakar; J Srinivasappa; U Ray
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.

Authors:  J F Woodruff; J J Woodruff
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

Review 6.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

7.  Use of cRNA digoxigenin-labelled probes for detection of enteroviruses in humans and in the environment.

Authors:  F Fuchs; I Leparc; H Kopecka; D Garin; M Aymard
Journal:  J Virol Methods       Date:  1993-05       Impact factor: 2.014

8.  Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides.

Authors:  M Brytting; V A Sundqvist; P Stålhandske; A Linde; B Wahren
Journal:  J Virol Methods       Date:  1991-05       Impact factor: 2.014

9.  Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy.

Authors:  N E Bowles; P J Richardson; E G Olsen; L C Archard
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

10.  A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3.

Authors:  M P Reyes; K L Ho; F Smith; A M Lerner
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

View more
  5 in total

1.  Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.

Authors:  H Zhang; P Morgan-Capner; N Latif; Y A Pandolfino; W Fan; M J Dunn; L C Archard
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome.

Authors:  I Leparc-Goffart; J Julien; F Fuchs; I Janatova; M Aymard; H Kopecka
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Detection of infectious enteroviruses, enterovirus genomes, somatic coliphages, and Bacteroides fragilis phages in treated wastewater.

Authors:  C Gantzer; A Maul; J M Audic; L Schwartzbrod
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

4.  Reverse transcriptase PCR detection of astrovirus, hepatitis A virus, and poliovirus in experimentally contaminated mussels: comparison of several extraction and concentration methods.

Authors:  O Traore; C Arnal; B Mignotte; A Maul; H Laveran; S Billaudel; L Schwartzbrod
Journal:  Appl Environ Microbiol       Date:  1998-08       Impact factor: 4.792

5.  Differential detection of rhinoviruses and enteroviruses RNA sequences associated with classical immunofluorescence assay detection of respiratory virus antigens in nasopharyngeal swabs from infants with bronchiolitis.

Authors:  L Andréoletti; M Lesay; A Deschildre; V Lambert; A Dewilde; P Wattré
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.